VYGR Voyager Therapeutics, Inc.
P/E
--
Forward P/E
8.44
Price/Sales
6.18
Beta
1.266
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Voyager Presents Favorable Preclinical Data for Alzheimer's Gene Therapy Candidate VY1706
Voyager Therapeutics announced positive good laboratory practice (GLP) toxicology data for VY1706, its investigational tau silencing gene therapy for...
🔴 Voyager Therapeutics is trading 5.2% down today as risk-off sentiment pressures the biotech sector
Voyager Therapeutics is trading 5.2% down at $3.26 as risk-off sentiment hits the biotech sector, extending a multi-session slide from recent highs. • The...
🔴 Voyager Therapeutics is trading 5.4% down today with no clear catalyst
Voyager Therapeutics is trading 5.4% down at $3.48 amid light company news flow and a generally mixed broader market backdrop. • The stock's move appears tied...
🟢 VYGR is trading 5.3% up today following recent FDA IND clearance for VY1706 and upcoming AAIC presentation
• Voyager Therapeutics (VYGR) is trading 5.3% up today at $3.81. • The company recently received FDA Investigational New Drug (IND) clearance for VY1706, its...